1.Incidence of Contrast-induced Nephropathy in Patients Undergoing Coronary Angiography: An Annual Review in A University Hospital
Katherine Ann N TAN ; John Patrick F ONA ; Marcellus Francis L RAMIREZ ; Wilson L TAN DE GUZMAN
Journal of Medicine University of Santo Tomas 2018;2(1):185-191
Introduction:
The rapidly growing number of percutaneous coronary interventions has led to a considerable improvement in the outcome of patients
with acute coronary syndromes, yet concurrently
exposing patients to enormous volumes of contrast
media with the inherent risk of renal function impairment.
Objective:
To determine the incidence of contrast induced nephropathy of patients admitted at
University of Santo Tomas Hospital (USTH) who
underwent coronary angiography with or without
Percutaneous Transluminal Coronary Angioplasty
(PTCA).
Methodology:
This is a retrospective, descriptive
study including patients aged 18 years and above,
of any gender, admitted at the USTH from January
1, 2016 to December 31, 2016, who underwent
coronary angiography with or without PTCA with
baseline and follow up creatinine levels 48-72 hours
after the procedure. Data were retrieved by review
of medical records of these patients.
Results:
Three out of 78 patients (3.8%) had elevated creatinine but all three patients also underwent
major surgery within 48 hours after coronary angiography which could explain the renal impairment.
Conclusion
Although contrast induced nephropathy was described as the third most common cause
of new Acute Kidney Injury in hospitalized patients,
it was accordingly nil among those who underwent
coronary angiography at USTH from January to
December 2016. Benefi ts and risks of undergoing
coronary angiography should always be weighed individually. Risk stratifi cation scores should only
serve as a guide in managing patients and proper
preventive measures should be applied.
Coronary Angiography
;
ErbB Receptors
2.The University of Santo Tomas Hospital (USTH) 2022 Institutional Chest Pain Pathway: Approach to diagnosis, risk stratification, and management.
Jannah Lee TARRANZA ; Christine Joy BONGON ; Maria Monica VALDEZ ; John Paul TIOPIANCO ; Alexander REYES ; John Patrick ONA ; Don Robespierre REYES ; Marcellus Francis RAMIREZ ; Aileen Cynthia DE LARA ; Clarissa MENDOZA ; Wilson Tan DE GUZMAN ; Zacarias MANUEL ; Eduardo S. CAGUIOA ; Milagros YAMAMOTO
Journal of Medicine University of Santo Tomas 2022;6(S1):11-24
This clinical pathway for the diagnosis and risk stratification of patients presenting with acute chest pain, including acute coronary syndromes, provides recommendations and algorithms for clinicians to diagnose, risk stratify, and manage acute chest pain in adult patients. The writing committee reviewed existing international and local guidelines. Modifications to the algorithm following face-to-face and virtual meetings resulted in expert decisions written as recommendations and presented in a flow diagram format. The USTH Chest Pain Pathway provides guidance based on current guidelines and recommendations on assessing and evaluating acute chest pain, tailored to local needs and institution-specific facilities. We recommend its use to ensure quality patient care in the hospital.
Acute Coronary Syndrome|critical Pathways